A Comparison of Ranibizumab and Aflibercept for the Development of Geographic Atrophy in (Wet) AMD Patients
Clinical trial NCT02130024 · COMPLETED
Trial details
- NCT number
- NCT02130024
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-11
- Primary completion
- 2017-11-15
- Enrollment
- 281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.